Skip to content

Iron and the Breast-Fed Infant: Iron Status and Two Regimens of Iron Supplementation

Iron and the Breast-Fed Infant: Iron Status and Two Regimens of Iron Supplementation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00760890
Acronym
BFe01B1
Enrollment
171
Registered
2008-09-26
Start date
2001-06-30
Completion date
2005-10-31
Last updated
2008-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency

Keywords

Iron, breastfed infant

Brief summary

Normal breastfed infants can develop iron deficiency by 6 months of age. This trial tested the hypothesis that regular provision of a source of iron beginning at 4 months of age improves iron status and could prevent iron deficiency. This was a prospective randomized trial involving breastfed infants. To be eligible, infants had to be predominantly breastfed (\<200 ml/day of formula) at 4 months of age. At 4 months infants were randomly assigned to one of two interventions or to control. The interventions consisted in the daily administration of medicinal iron in a dose of 7.5 mg (Medicinal Iron Group) or in the daily feeding of one jar of an iron-fortified cereal providing 7 mg of iron each day (Cereal Group). The control group received complementary foods chosen by he parents but no source of iron provided by the investigators. The interventions took place from 4 to 9 months. All infants were subsequently followed to 2 years of age.

Interventions

DIETARY_SUPPLEMENTFer-In-Sol (ferrous sulfate)

7.5 mg/day in the form of 0.3 ml once each day

DIETARY_SUPPLEMENTIron fortified cereal

1 jar each day of one of three wet pack cereals manufactured by the Gerber Company: Each jar provided 7 mg of ferrous sulfate.

Sponsors

National Institutes of Health (NIH)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 24 Months
Healthy volunteers
Yes

Inclusion criteria

* Predominantly breastfed (at 4 months) term infants

Exclusion criteria

* Not predominantly breastfed at 4 months * Premature infants

Design outcomes

Primary

MeasureTime frame
Iron status3 times during the intervention

Secondary

MeasureTime frame
GrowthAt the end of intervention
Tolerance (gastrointestinal)During intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026